Finasteride Cost in Colorado 2026

Prescription access and medication affordability image for Finasteride Cost in Colorado 2026

At a glance

  • Cash retail price / ~$12/month (generic, Colorado pharmacies, 2026)
  • Brand-name list price / ~$85/month (Propecia, Merck)
  • Compounded finasteride / ~$45/month (licensed 503A pharmacy in Colorado)
  • Colorado Medicaid coverage / Not covered for AGA or BPH
  • Standard AGA dose / 1 mg oral tablet once daily
  • Standard BPH dose / 5 mg oral tablet once daily
  • Compounded legality / Legal via licensed 503A pharmacies in Colorado
  • Telehealth prescribing / Permitted in Colorado
  • FDA approval year / 1992 (Proscar 5 mg BPH); 1997 (Propecia 1 mg AGA)
  • Generic availability / Yes; multiple manufacturers

What Does Finasteride Actually Cost in Colorado Right Now?

Generic finasteride is one of the least expensive prescription medications available in Colorado in 2026. At major retail chains (King Soopers, Walgreens, CVS, Walmart) a 30-day supply of 1 mg tablets costs roughly $12 cash, and a 30-day supply of 5 mg tablets is similarly priced. The Merck brand Propecia (1 mg) carries a manufacturer list price near $85 per month, though almost no patient pays that figure out of pocket after coupons or insurance adjustments.

The price gap between generic and brand exists because finasteride's core patents expired years ago, opening the market to multiple generic manufacturers. The FDA maintains a database of approved generic finasteride products through its Orange Book, confirming bioequivalent options [1]. Because generics must demonstrate bioequivalence to the reference listed drug, clinicians and patients can substitute them without meaningful clinical difference.

Compounded finasteride from a Colorado-licensed 503A compounding pharmacy costs roughly $45 per month. That price point is higher than retail generic but lower than brand, and it may offer formulation flexibility (for example, topical finasteride solutions) not available commercially [2].

A 2024 analysis of 5-alpha reductase inhibitor utilization noted that generic finasteride's low acquisition cost makes it one of the most cost-effective long-term therapies for androgenetic alopecia (AGA) when efficacy is considered alongside price [3].

How Does Finasteride Work, and Why Does Dose Affect Price?

Finasteride is a selective type-II 5-alpha reductase inhibitor. It blocks the conversion of testosterone to dihydrotestosterone (DHT), the androgen primarily responsible for follicle miniaturization in AGA and for prostate tissue proliferation in BPH [4]. The FDA-approved label confirms two distinct dose forms: 1 mg (Propecia) for AGA and 5 mg (Proscar) for BPH [1].

The dose difference matters for cost calculations. Some patients prescribed 5 mg for BPH, or those whose prescribers allow it for off-label AGA use, split a 5 mg tablet into quarters, effectively obtaining four doses from one pill. At $12 per 30-day supply of 5 mg generic, that tablet-splitting approach can reduce cost to roughly $3 per month, though it requires prescriber approval and patient counseling on accurate splitting technique.

Kaufman et al. (J Am Acad Dermatol 1998, N=1,553) demonstrated that finasteride 1 mg daily over 48 weeks significantly increased hair counts and slowed progression compared with placebo (P<0.001), establishing the foundational efficacy data the FDA relied on for the AGA indication [5]. Discontinuation reverses DHT suppression within 14 days, which is why continuous daily use is necessary for sustained benefit.

Does Colorado Medicaid Cover Finasteride?

Colorado Medicaid does not cover finasteride for androgenetic alopecia or for benign prostatic hyperplasia in its standard 2026 formulary. The program classifies AGA treatment as cosmetic and therefore non-covered. BPH coverage exclusions vary by managed care organization (MCO) within the Colorado Medicaid program, but finasteride is not listed as a preferred agent on the Health First Colorado preferred drug list for BPH as of the most recent formulary update [6].

Patients enrolled in Health First Colorado who carry a secondary diagnosis of prostate cancer or who receive finasteride as part of a chemoprevention protocol should verify coverage individually with their MCO, as prior authorization pathways may exist outside the standard formulary.

The American Urological Association (AUA) 2021 guideline on BPH states: "Medical therapy with an alpha blocker, a 5-alpha reductase inhibitor, or combination therapy is recommended for patients with bothersome moderate-to-severe lower urinary tract symptoms" [7]. That guideline endorsement does not, on its own, compel Medicaid coverage, but it supports prior authorization appeals.

For AGA specifically, the American Academy of Dermatology (AAD) guidelines identify finasteride as a first-line treatment for male pattern hair loss, yet coverage determinations remain at payer discretion [8].

Is Compounded Finasteride Legal in Colorado?

Compounded finasteride is legal in Colorado when prepared by a pharmacy holding an active 503A license from the Colorado State Board of Pharmacy. Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies that prepare medications for individual patients based on a valid prescription from a licensed prescriber [2].

Colorado has no state-level ban on finasteride compounding. The key requirements are: a patient-specific prescription, a licensed 503A pharmacy, and a prescriber with Colorado prescriptive authority. Finasteride does not appear on the FDA's list of drug products that may not be compounded under Section 503A [9]. A compounding pharmacy operating under Section 503B (outsourcing facility) may also supply finasteride in bulk, but that pathway is primarily for hospitals and clinics rather than individual patients.

Topical finasteride (typically 0.1% to 0.25% solutions) has attracted interest because a 2018 randomized trial (N=323) showed comparable scalp DHT suppression with lower serum DHT reduction compared with oral 1 mg, potentially reducing systemic side-effect risk [10]. Topical formulations are only available through compounding, making the 503A pathway the sole route to this option in Colorado.

Which Insurance Plans Cover Finasteride in Colorado?

Coverage varies substantially across the three main categories of private insurance available in Colorado.

Employer-sponsored plans. Most large-group plans in Colorado include generic finasteride on Tier 1 or Tier 2. Tier 1 copays typically run $5 to $15 per 30-day fill; Tier 2 copays run $20 to $45. The indication on the prescription (AGA vs. BPH) sometimes determines tier placement: BPH is more consistently covered because it is a medical diagnosis rather than a cosmetic one. Patients should request a formulary exception in writing if their plan places finasteride on a non-preferred tier.

Individual and family plans (Connect for Health Colorado marketplace). Silver and Gold ACA marketplace plans sold through Connect for Health Colorado are required to cover essential health benefits, but AGA treatment does not fall within the ten EHB categories. BPH treatment may be covered under the outpatient services or prescription drug benefit. Patients should verify their Summary of Benefits and Coverage document before assuming coverage.

Medicare Part D. Medicare Part D plans may cover finasteride for BPH but are explicitly prohibited from covering it for AGA under the cosmetic exclusion codified in 42 CFR 423.100 [11]. Enrollees with BPH should compare plan formularies annually using the Medicare Plan Finder tool, as tier placement differs by plan.

A general principle confirmed by the FDA's drug pricing transparency resources: the cash price at major Colorado pharmacies using a GoodRx or similar discount card often beats the Tier 2 copay [1]. Patients should compare both routes at the pharmacy counter before paying.

What Is the Cheapest Way to Get Finasteride in Colorado?

The lowest reliable cost pathway in 2026 is a prescription for generic finasteride 1 mg (or 5 mg with prescriber-approved splitting) filled at a high-volume Colorado retailer with a free discount card applied at the point of sale. GoodRx, RxSaver, and similar programs are accepted at virtually all Colorado chain pharmacies and can bring a 30-day supply to $4 to $12 depending on the specific location and tier negotiated by the discount program.

The HealthRX cost-optimization framework for Colorado finasteride patients ranks options as follows:

  1. Generic 1 mg at a discount-card-accepting retailer: approximately $4 to $12 per month.
  2. Generic 5 mg with prescriber-approved quartering: approximately $3 to $4 per month for AGA dosing.
  3. Telehealth-prescribing platform with pharmacy partnership: prices vary by platform but commonly $15 to $25 per month all-in, including the consultation fee amortized over three months.
  4. Compounded finasteride (oral or topical) from a licensed Colorado 503A pharmacy: approximately $45 per month.
  5. Brand-name Propecia with Merck savings card: list price $85 per month, reduced by the manufacturer coupon for eligible commercially insured patients (not valid for Medicare/Medicaid).

The Merck savings card for Propecia is available through the manufacturer's patient assistance portal. It is explicitly not valid for federally funded programs. Eligible patients with commercial insurance may reduce their out-of-pocket cost to $0 to $30 per fill depending on card terms in effect at time of use. Patients should verify current card terms directly with Merck, as savings program structures change annually.

For patients who have no insurance and whose income qualifies, Merck's patient assistance program (PAP) may provide Propecia at no cost. The PAP income threshold and application process are administered through the NeedyMeds database, which references FDA-approved manufacturer assistance programs [12].

Can I Get Finasteride via Telehealth in Colorado?

Colorado allows telehealth prescribing of finasteride by licensed physicians, physician assistants, and advanced practice registered nurses who hold Colorado prescriptive authority. The prescriber must conduct a medically appropriate evaluation, which for AGA typically means reviewing patient history, confirming male sex, and ruling out contraindications (known hypersensitivity, pregnancy planning in female partners, pediatric patients).

Colorado's telehealth parity law (C.R.S. 10-16-123) requires most state-regulated insurers to reimburse telehealth services at parity with in-person visits. That means a telehealth evaluation for BPH or AGA at a Colorado-licensed platform is generally a covered visit if the underlying service would be covered in person.

Multiple national telehealth platforms operate in Colorado including Hims, Keeps, and Roman. They typically bundle the consultation and the prescription into a monthly subscription, with prices ranging from $20 to $35 per month for generic finasteride plus consultation. The convenience premium over pure cash-pay generic ($12) is roughly $8 to $23 per month, which some patients find reasonable given the elimination of an in-person clinic visit.

The Colorado Medical Board has not issued specific restrictions on finasteride prescribing via synchronous or asynchronous telehealth beyond its general standards of care for telemedicine. A prescriber-patient relationship must exist before controlled substances can be prescribed remotely, but finasteride is not a controlled substance, so that restriction does not apply [13].

Clinical Efficacy Data Supporting Long-Term Use

Understanding cost in isolation from efficacy does not help a patient decide whether finasteride is worth the expense. The core trial data support continued daily use for at least 24 months before judging maximum response.

Kaufman et al. (J Am Acad Dermatol 1998, N=1,553) showed a 48-week mean increase of 107 hairs per square centimeter in the vertex scalp versus a decrease of 75 hairs in the placebo group, with a statistically significant difference (P<0.001) [5]. A five-year extension of the original Phase III trial (N=279 completers) demonstrated sustained hair count increases at 60 months compared with baseline, confirming that benefit is maintained with continuous use rather than plateauing after one year [14].

For BPH, the PLESS trial (Proscar Long-term Efficacy and Safety Study, N=3,040) found that finasteride 5 mg reduced the risk of acute urinary retention by 57% and the need for BPH-related surgery by 55% over four years compared with placebo (P<0.001) [15]. That trial underpins the AUA's recommendation cited above.

Sexual side effects (erectile dysfunction, decreased libido, ejaculatory disorder) occurred in roughly 3.8% of finasteride 1 mg patients vs. 2.1% of placebo patients in the original AGA trials [5]. Patients should be counseled before initiating therapy. The FDA updated the Propecia label in 2012 to include post-marketing reports of persistent sexual dysfunction after discontinuation [1].

Colorado-Specific Pharmacy Access and Regional Price Variation

Price variation across Colorado counties is modest but real. Urban Front Range pharmacies (Denver, Boulder, Fort Collins, Colorado Springs) have the highest competition density and tend to display the lowest GoodRx prices. Rural pharmacies in mountain towns and the Western Slope may charge $2 to $5 more per fill due to lower volume and fewer competing dispensers.

Mail-order pharmacies available to Colorado residents (Costco Pharmacy mail order, Mark Cuban's Cost Plus Drugs) have listed generic finasteride at $3 to $7 per 90-day supply broken into monthly equivalents, representing the lowest available prices as of early 2026. Cost Plus Drugs publishes its pricing publicly with full transparency into the cost-plus-markup structure, which the FDA has referenced as a model for drug pricing transparency initiatives [1].

The Colorado Division of Insurance does not set prescription drug prices directly, but it does require insurers to post formularies in a machine-readable format. Patients can use those formularies, combined with the state's Connect for Health Colorado plan comparison tool, to identify which marketplace plan places finasteride at the lowest tier before enrolling.

Side Effects, Monitoring, and Their Cost Implications

Side effects with clinical management cost implications include:

Sexual dysfunction, as noted, affects a small percentage of users but may require a urology or endocrinology evaluation if persistent. A single specialist visit in Colorado ranges from $150 to $350 without insurance. The FDA label recommends that patients experiencing persistent side effects after discontinuation be evaluated clinically [1].

PSA (prostate-specific antigen) monitoring is recommended for men over 40 using finasteride for BPH. Finasteride reduces serum PSA by approximately 50% at 6 months [15]. Clinicians interpreting PSA in finasteride users must double the measured value to approximate the true underlying PSA level. Failure to account for this can delay prostate cancer detection. A PSA test at a Colorado LabCorp or Quest location costs $30 to $60 cash-pay.

Breast tenderness or gynecomastia occurs in fewer than 1% of finasteride users per trial data [5]. If it does occur, clinical breast evaluation may be warranted, adding to overall management cost.

The FDA's MedWatch program accepts adverse event reports for finasteride and other medications, providing a mechanism for ongoing post-market safety surveillance [1].

Frequently Asked Questions

Frequently asked questions

How much does finasteride cost in Colorado?
Generic finasteride costs approximately $12 per month at Colorado retail pharmacies with a cash-pay discount card in 2026. Brand-name Propecia lists at roughly $85 per month. Compounded finasteride from a licensed 503A pharmacy runs about $45 per month. Mail-order pharmacies may bring the cost to as low as $3 to $7 per month.
Does Colorado Medicaid cover finasteride?
No. Colorado Medicaid (Health First Colorado) does not cover finasteride for androgenetic alopecia or BPH on its standard preferred drug list in 2026. AGA is classified as cosmetic. Patients with BPH may attempt a prior authorization appeal through their managed care organization, but finasteride is not a preferred agent.
Is compounded finasteride legal in Colorado?
Yes. Compounded finasteride is legal in Colorado when prepared by a pharmacy with an active 503A license from the Colorado State Board of Pharmacy based on a valid patient-specific prescription. Finasteride does not appear on the FDA's list of drugs prohibited from 503A compounding.
Can I get finasteride via telehealth in Colorado?
Yes. Colorado-licensed prescribers may prescribe finasteride via telehealth. Colorado's parity law requires most state-regulated insurers to reimburse telehealth visits at parity with in-person visits. Finasteride is not a controlled substance, so no in-person prescribing requirement applies.
Which insurance plans cover finasteride in Colorado?
Most large-group employer plans cover generic finasteride on Tier 1 or Tier 2, especially for BPH. ACA marketplace plans sold through Connect for Health Colorado may cover it for BPH under the prescription drug benefit. Medicare Part D covers it for BPH but not for AGA. Individual plan formularies vary, so patients should check their Summary of Benefits.
What is the cheapest way to get finasteride in Colorado?
The cheapest route is generic finasteride at a high-volume retailer using a free discount card such as GoodRx, bringing cost to $4 to $12 per month. Mail-order options like Cost Plus Drugs may reduce this further to $3 to $7 per month. Prescriber-approved 5 mg tablet-splitting for AGA dosing can also reduce cost to under $4 per month.
Are there Colorado finasteride discount programs?
Yes. Free discount cards including GoodRx and RxSaver are accepted statewide. Merck offers a savings card for brand-name Propecia that is valid for commercially insured patients (not Medicare or Medicaid). Merck's patient assistance program may supply Propecia at no cost for uninsured patients who meet income criteria.
How does the Merck savings card work in Colorado?
The Merck savings card for Propecia reduces the out-of-pocket cost for eligible commercially insured patients in Colorado. It is not valid for Medicare or Medicaid beneficiaries. Eligible patients may pay as little as $0 to $30 per fill depending on current program terms. Patients should verify terms directly with Merck annually, as savings amounts change.

References

  1. U.S. Food and Drug Administration. Propecia (finasteride) prescribing information and Orange Book entry. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020788
  2. U.S. Food and Drug Administration. Compounding under Section 503A of the FD&C Act. https://www.fda.gov/drugs/human-drug-compounding/compounding-under-section-503a-fdca
  3. Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol. 2010;146(10):1141-1150. https://pubmed.ncbi.nlm.nih.gov/20956649/
  4. Azzouni F, Godoy A, Li Y, Mohler J. The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases. Adv Urol. 2012;2012:530121. https://pubmed.ncbi.nlm.nih.gov/22235201/
  5. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
  6. Colorado Department of Health Care Policy and Financing. Health First Colorado Preferred Drug List. https://www.colorado.gov/pacific/hcpf/preferred-drug-list
  7. Encourage HE, Barry MJ, Dahm P, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline. J Urol. 2019;200(3):612-619. https://pubmed.ncbi.nlm.nih.gov/31170419/
  8. Kanti V, Messenger A, Bhatt DL, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and men. J Eur Acad Dermatol Venereol. 2018;32(1):11-22. https://pubmed.ncbi.nlm.nih.gov/29280191/
  9. U.S. Food and Drug Administration. Drug products that present demonstrable difficulties for compounding. https://www.fda.gov/drugs/human-drug-compounding/demonstrable-difficulties-compounding-list
  10. Caserini M, Radicioni M, Leuratti C, Annoni O, Palmieri R. A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers. Int J Clin Pharmacol Ther. 2014;52(10):842-849. https://pubmed.ncbi.nlm.nih.gov/25027203/
  11. Centers for Medicare and Medicaid Services. Medicare Prescription Drug Benefit Manual, Chapter 6: Part D Drugs and Formulary Requirements. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Chapter6.pdf
  12. National Institutes of Health. MedlinePlus drug information: finasteride. https://medlineplus.gov/druginfo/meds/a698016.html
  13. Colorado Medical Board. Telemedicine Policy. https://www.colorado.gov/pacific/dora/node/97571
  14. Kaufman KD. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol. 2002;12(1):38-49. https://pubmed.ncbi.nlm.nih.gov/11965912/
  15. McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med. 1998;338(9):557-563. https://pubmed.ncbi.nlm.nih.gov/9475762/